Additional file 1: of MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells

Figure S1. Anti-PD-L1 antibody exhibited in vivo activity on GV369-CON B-cell lymphoma. A and B: CD8+T cell percentage was enhanced, as well as CD8+T cell apoptosis and Fas expression were inhibited in GV369-CON group treated with anti-PD-L1 antibody. C and D: Expression of p-AKT and p-ERK on CD8+T cells was significantly upregulated in GV369-CON group treated with anti-PD-L1 antibody. (JPG 724 kb)